Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/27/2025

Hyponatremia Management

Clinical Considerations

  • The American Geriatrics Society recommends that patients on thiazides should have electrolytes monitored to prevent severe hyponatremia, with monitoring within 1-2 weeks of initiation, with dose increases, and at least yearly 1
  • The American Geriatrics Society guidelines note that ACE inhibitors combined with thiazides can cause hyperkalemia, particularly in elderly patients with diabetes, and recommend close monitoring of renal function and potassium levels 1, 2
  • Hyperkalemia at a level of 5.9 mEq/L typically does not cause agitation or irritability, but rather cardiac arrhythmias and muscle weakness when severe, and may be secondary to ACE inhibitors in the setting of renal dysfunction from volume depletion 2, 3
  • The corrected calcium level should be calculated when evaluating hypercalcemia in patients with severely low albumin levels, as a low albumin level can affect the total calcium measurement 4

Treatment and Monitoring

  • The American Geriatrics Society recommends discontinuing thiazide diuretics immediately in patients with severe hyponatremia, and monitoring electrolytes closely to prevent osmotic demyelination syndrome 1, 5

Risk of Electrolyte Disturbances with Thiazide‑ACE Inhibitor Combination in Elderly Diabetic Patients

Hyponatremia Risk

  • In elderly patients with diabetes, concurrent administration of a thiazide diuretic and an ACE inhibitor (e.g., lisinopril) substantially raises the likelihood of severe hyponatremia by impairing free‑water excretion and altering renal sodium handling【6】.

Hyperkalemia Risk

  • The same thiazide‑ACE inhibitor combination can precipitate hyperkalemia through volume depletion and diminished renal potassium excretion, particularly when renal function is declining【6】.